ROCHESTER, N.Y., May 18, 2015 /PRNewswire/ -- Vuzix® Corporation (NASDAQ: VUZI), a leading supplier of Video Eyewear and Smart Glasses products in the consumer, commercial and entertainment markets, today announced a new partnership with Octovis, Inc., the creator of a telemedicine platform – Telle™ – which integrates Vuzix' M100 Smart Glasses technology. Octovis, Inc. is now shipping and has received substantial interest from industry leaders after deploying its highly mobile telemedicine platform to multiple medical facilities throughout the United States.
Octovis' secure, HIPAA compliant Telle™ platform combines multiple Bluetooth® enabled medical devices, such as an EKG, pulse oximeter, stethoscope, otoscope, and others, to bring the examination room to the patient's bedside. With the addition of these devices, the Vuzix M100 allows a local caregiver to act as the eyes and ears of a remote physician located anywhere in the world. Enabled by Octovis' cloud services, caregivers can now collaborate in real time, a connection previously not possible with traditional telephonic and video based approaches. With Telle™, quality care is no longer restricted to medical rooms and hospitals.
Paul Travers, President and CEO of Vuzix, said, "This partnership underscores how our M100 technology continues to enable advances in the medical field, an area that remains a focus for Vuzix. We are excited to see Octovis shipping Telle as medical professionals can now utilize our smart glasses technology with Octovis' Telle™ application to share critical patient information in real-time to vastly improve the quality of remote patient care."
"We created Telle™ as a way to extend the reach of physicians while not sacrificing medical context in the name of efficiency, an aspect inherent in many telemedicine approaches." said Ryan Macy, President and CEO of Octovis Inc. "With the Vuzix M100 and our other integrated devices, we are able to create a truly immersive engagement for patient care. This has led to improvements across the board, one of the most significant being measurable reductions in hospital readmissions for the post-acute care market. The Vuzix M100 adds a point of view perspective to the most important focus, the patient."
The Vuzix M100 Smart Glasses are a hands free glasses worn display and wearable computer designed for the enterprise, industrial, and medical user. The M100 contains a virtual display with an integrated camera and a powerful processing engine, running the Android® OS to wirelessly connect via Bluetooth or WiFi directly to most standard networks or to a smartphone or other compatible device.
About Vuzix Corporation
Vuzix is a leading supplier of Video Eyewear and Smart Glasses products in the consumer, commercial and entertainment markets. The Company's products include personal display and wearable computing devices that offer users a portable high quality viewing experience, provide solutions for mobility, wearable displays and virtual and augmented reality. Vuzix holds 41 patents and 10 additional patents pending and numerous IP licenses in the Video Eyewear field. The Company has won Consumer Electronics Show (or CES) awards for innovation for the years 2005 to 2014 and several wireless technology innovation awards among others. Founded in 1997, Vuzix is a public company (VUZI) with offices in Rochester, NY, Oxford, UK and Tokyo, Japan.
About Octovis, Inc.
Octovis is a leading provider of mobile telemedicine technologies and services to the healthcare industry. Its primary product, Telle™, offers one of the most integrated mobile telemedicine platforms in Healthcare. Founded in 2014, Octovis is a privately held, Nashville-based company with additional offices in New York, NY and San Francisco, CA.
Forward-Looking Statements Disclaimer
Certain statements contained in this news release are "forward-looking statements" within the meaning of the Securities Litigation Reform Act of 1995 and applicable Canadian securities laws. Forward looking statements contained in this release relate to the success of the partnership with Octovis, the usefulness of the Telle and Vuzix solution, future business revenues and opportunities, and the value of current IP portfolio, among other things, and the Company's leadership in the Video Eyewear and AR display industry. They are generally identified by words such as "believes," "may," "expects," "anticipates," "should" and similar expressions. Readers should not place undue reliance on such forward-looking statements, which are based upon the Company's beliefs and assumptions as of the date of this release. The Company's actual results could differ materially due to risk factors and other items described in more detail in the "Risk Factors" section of the Company's Annual Reports and MD&A filed with the United States Securities and Exchange Commission and applicable Canadian securities regulators (copies of which may be obtained at www.sedar.com or www.sec.gov ). Subsequent events and developments may cause these forward-looking statements to change. The Company specifically disclaims any obligation or intention to update or revise these forward-looking statements as a result of changed events or circumstances that occur after the date of this release, except as required by applicable law.
For further information contact:
Investor and Media Relations Contact:
Andrew Haag Managing Partner IRTH Communications email@example.com 877-368-3566
For further Vuzix sales, and product information, please visit: North America: http://www.vuzix.com/contact/ Europe/UK: http://www.vuzix.com/UKSITE/contact/index.html Asia: http://www.vuzix.jp/contact.html
SOURCE Vuzix Corporation